Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 2/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526544 | 0.71 | GRM4 (0.32) | PDE2APDE10AGRM4 | |
| SCHEMBL15064402 | 0.68 | KDM4E (0.51) | KDM4EALDH1A1 | |
| SCHEMBL33526541 | 0.68 | — | — | |
| SCHEMBL14060011 | 0.67 | MAPT (0.53) | — | |
| SCHEMBL25975555 | 0.67 | KDM4E (0.36) | KDM4EALDH1A1 | |
| SCHEMBL25974823 | 0.67 | KDM4E (0.36) | KDM4EALDH1A1 | |
| SCHEMBL15472079 | 0.66 | PIK3CA (0.41) | ALDH1A1 | |
| SCHEMBL12093598 | 0.66 | PIK3CA (0.44) | — | |
| SCHEMBL25975742 | 0.66 | KDM4E (0.38) | KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL23501360 | 0.66 | MAPT (0.51) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | KDM4E 2674/4885ALDH1A1 3578/4885PDE2A 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.